HIGHLIGHTS
- who: Chen-Yi Chiang from the National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan have published the paper: Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy, in the Journal: (JOURNAL)
- what: The authors report the discovery of mAb-S5 using a DNA prime-protein boost strategy, which is a highly potent neutralizing antibody against authentic variants WA1, D614G, Alpha, and Gamma that blocks ACE2 binding through an interaction with the RBD. The authors show that mAb-S5 is potent . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.